TFRC and glioblastoma: Several previous studies have successfully inhibited the proliferation and invasion of various tumor cells, such as glioblastoma, lymphoma, ovarian cancer, and hepatocellular carcinoma cells, by inhibiting the TFRC gene (43–46).